Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection

Journal article

Open access

Peer reviewed

P. J Friend, G Hale, L Chatenoud, P Rebello, J Bradley, S Thiru, J. M Phillips and H Waldmann

Transplantation, Vol.68(11), pp.1632-1637

15/12/1999

PMID: 10609938

Abstract

Biological and medical sciences

Immunomodulators

Medical sciences

Pharmacology. Drug treatments

url

https://doi.org/10.1097/00007890-199912150-00005View

Published (Version of record) Open

1 Record Views

Title: Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection
Creators - without role: P. J Friend - Addenbrooke's Hospital
G Hale - University of Cambridge
L Chatenoud - Necker Hospital, Paris, France
P Rebello - University of Cambridge
J Bradley - University of Cambridge
S Thiru - University of Cambridge
J. M Phillips - University of Cambridge
H Waldmann - University of Cambridge
Publication Details: Transplantation, Vol.68(11), pp.1632-1637
Publisher: Lippincott
Identifiers: 9933096408331
Academic Unit: University of Jeddah
Language: English
Resource Type: Journal article